Northpond Ventures, LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-11 7:51 pm Purchase | 2025-06-04 | 13G | Mereo BioPharma Group plc MREO | Northpond Ventures, LP | 54,521,000 6.900% | 54,521,000 (New Position) | Filing |